Ambev S.A. (LON:0A6X)
2.559
+0.068 (2.73%)
At close: Jan 9, 2026
Ambev Market Cap
Ambev has a market cap or net worth of 30.17 billion as of January 9, 2026. Its market cap has increased by 15.82% in one year.
Market Cap
30.17B
Enterprise Value
27.91B
Revenue
12.63B
Ranking
n/a
PE Ratio
13.48
Stock Price
2.56
Market Cap Chart
Since November 11, 2013, Ambev's market cap has decreased from 45.31B to 30.17B, a decrease of -33.42%. That is a compound annual growth rate of -3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 30.17B | 3.73% |
| Dec 30, 2025 | 29.09B | 22.88% |
| Dec 30, 2024 | 23.67B | -32.47% |
| Dec 28, 2023 | 35.05B | -3.03% |
| Dec 29, 2022 | 36.15B | 12.12% |
| Dec 30, 2021 | 32.24B | -7.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.48B |
| HSBC Holdings | 204.76B |
| Shell | 150.73B |
| Rolls-Royce Holdings | 108.65B |
| Unilever | 103.21B |
| Rio Tinto Group | 101.78B |
| British American Tobacco p.l.c. | 88.20B |
| GSK plc | 75.67B |